![Carey Ng](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Carey Ng
Direttore/Membro del Consiglio presso
IMMIX BIOPHARMA, INC.
Patrimonio netto: 15 M $ in data 31/08/2026
Profilo
Carey J.
Ng is currently Managing Director at Mesa Verde Ventures LLC since 2013 and at Mesa Verde Venture Partners LP since 2013.
Dr. Ng serves as Director at Satiogen Pharmaceuticals, Inc., Elysium Therapeutics, Inc., Paradigm Diagnostics, Inc., and MatriSys Bioscience, Inc. Dr. Ng is Independent Director at Immix Biopharma, Inc. since 2019.
Formerly, Dr. Ng was Director at Biscayne Neurotherapeutics, Inc. Dr. Ng earned a doctorate from the University of California, Los Angeles in 2004 and an MBA from the University of California San Diego.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 22/05/2026 | 1.045.221 ( 1,46% ) | 15 M $ | 31/08/2026 |
Posizioni attive di Carey Ng
| Società | Posizione | Inizio |
|---|---|---|
| IMMIX BIOPHARMA, INC. | Direttore/Membro del Consiglio | 01/11/2019 |
Satiogen Pharmaceuticals, Inc.
 Satiogen Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops novel therapeutic treatments for diabetes and obesity | Direttore/Membro del Consiglio | - |
Mesa Verde Ventures LLC
 Mesa Verde Ventures LLC Investment ManagersFinance Mesa Verde Ventures invests in companies located in the United States primarily in California and the Southwest. The firm seeks investment opportunities in biotechnology and medical technology companies. It provides financing for early stage capital requirements. | Investitore di Private Equity | 01/01/2008 |
Paradigm Diagnostics, Inc.
 Paradigm Diagnostics, Inc. Medical SpecialtiesHealth Technology Manufactures diagnostic systems | Direttore/Membro del Consiglio | - |
Elysium Therapeutics, Inc.
 Elysium Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development in biotechnology | Direttore/Membro del Consiglio | - |
MatriSys Bioscience, Inc.
 MatriSys Bioscience, Inc. BiotechnologyHealth Technology Develops rational micro biome therapies | Direttore/Membro del Consiglio | - |
Mesa Verde Venture Partners LP
 Mesa Verde Venture Partners LP Investment ManagersFinance Acts as Venture Capital Fund | Corporate Officer/Principal | 01/12/2013 |
Precedenti posizioni note di Carey Ng
| Società | Posizione | Fine |
|---|---|---|
Biscayne Neurotherapeutics, Inc.
 Biscayne Neurotherapeutics, Inc. BiotechnologyHealth Technology Develops novel treatments for epilepsy, pain and other central nervous system disorders | Direttore/Membro del Consiglio | - |
Formazione di Carey Ng
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
45
Relazioni di 1° grado
10
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 10 |
|---|---|
Paradigm Diagnostics, Inc.
Paradigm Diagnostics, Inc. Medical SpecialtiesHealth Technology Manufactures diagnostic systems | Health Technology |
Mesa Verde Ventures LLC
Mesa Verde Ventures LLC Investment ManagersFinance Mesa Verde Ventures invests in companies located in the United States primarily in California and the Southwest. The firm seeks investment opportunities in biotechnology and medical technology companies. It provides financing for early stage capital requirements. | Finance |
University of California, Los Angeles
 University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California San Diego
 University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Satiogen Pharmaceuticals, Inc.
Satiogen Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops novel therapeutic treatments for diabetes and obesity | Commercial Services |
Mesa Verde Venture Partners LP
Mesa Verde Venture Partners LP Investment ManagersFinance Acts as Venture Capital Fund | Finance |
Biscayne Neurotherapeutics, Inc.
Biscayne Neurotherapeutics, Inc. BiotechnologyHealth Technology Develops novel treatments for epilepsy, pain and other central nervous system disorders | Health Technology |
MatriSys Bioscience, Inc.
MatriSys Bioscience, Inc. BiotechnologyHealth Technology Develops rational micro biome therapies | Health Technology |
Elysium Therapeutics, Inc.
Elysium Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development in biotechnology | Health Technology |
Immix Biopharma, Inc.
 Immix Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops therapies for cancer patients | Health Technology |
